Pierre DEHARO, Medical Doctor, MD PhD
Por um escritor misterioso
Descrição
Pierre DEHARO, Medical Doctor, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM, Service de cardiologie
Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome - Research and Practice in Thrombosis and Haemostasis
Catheterization and Cardiovascular Interventions: Vol 102, No 5
Futility Risk Model for Predicting Outcome After Transcatheter Aortic Valve Implantation - American Journal of Cardiology
EPs Push for More Involvement in TAVI Heart Team Discussions
Interactive Speaker
Pierre DEHARO, Medical Doctor, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM, Service de cardiologie
Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome - ScienceDirect
Provider Directory - Aetna Medicare
Dr. Yongmei Cha, MD, Rochester, MN, Cardiologist
Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies - The Lancet Global Health
incathlab on LinkedIn: #coronary #microcirculation #pci #microvascular #health #cardiology
Dr. Alexandros Briasoulis, MD – Rochester, MN
thomas modine on LinkedIn: #china #asia #research #science #innovation #health #medicine #education…
Pierre MORANGE, Chef de service, MD - PhD, Aix-Marseille Université, Marseille, AMU, Faculté de Médecine
de
por adulto (o preço varia de acordo com o tamanho do grupo)
